Keunwook Lee

Title: Innovations of Keunwook Lee in Protein Transduction

Introduction

Keunwook Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of protein transduction domains. His innovative work has the potential to enhance the delivery of therapeutic agents into living cells.

Latest Patents

Keunwook Lee holds a patent for a "Protein transduction domain, fusion compound containing the same, and pharmaceutical composition containing the fusion compound." This invention proposes a more efficient protein transduction domain and fusion compound. The research led to the discovery of a GK1 peptide comprising 18 amino acids, which can bond with high-molecular-weight materials such as proteins. This bonding allows these materials to penetrate living bodies, including cells, tissues, or blood, effectively. The fusion compound, oligonucleotide, or vector derived from this peptide can be utilized as a pharmaceutical composition for preventing or treating various diseases.

Career Highlights

Keunwook Lee's career is marked by his dedication to advancing biopharmaceutical technologies. His innovative approach to protein transduction has positioned him as a key figure in the field. He is currently associated with Genesen Co., Ltd., where he continues to explore new avenues for therapeutic applications.

Collaborations

Keunwook Lee has collaborated with notable colleagues, including Soo-Young Choi and Jin-Seu Park. Their combined expertise has contributed to the success of their research endeavors.

Conclusion

Keunwook Lee's work in protein transduction represents a significant advancement in biotechnology. His innovative approaches and collaborations are paving the way for new therapeutic solutions.